Xenikos
Manufacturing · Netherlands · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Wilhelminasingel 14, Nijmegen, Gelderlan...Phone Number
+31 243000100Website
www.xenikos.comRevenue
$6.3 MillionIndustry
About Xenikos
Is Xenikos your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Xenikos, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Xenikos has new funding data
Check if Xenikos has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Xenikos recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if Xenikos had a recent Job posting/layoffs
Product Launch: Get notified when Xenikos launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Xenikos
Check out if Xenikos is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Xenikos is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Xenikos is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Xenikos.
Xenikos financials insights
Gather financial insights about Xenikos, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series B
$30M
Debt
$47.3M
Xenikos Tech Stack
A closer look at the technologies used by Xenikos
Most Recent Scoops
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Xenikos
Xenikos, a private, clinical-stage biopharmaceutical company, is focused on developing innovative immunotherapies, based on toxin-conjugated antibodies, which are designed to quickly and safely reset the immune system in patients with a severe immune disease or post-transplantation rejection. The company was founded in 2009 and is headquartered in... Read More